We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.
Main Menu

ICR Clinical Trials and Statistics Unit

The Cancer Research UK funded ICR Clinical Trials and Statistics Unit (ICR-CTSU) is a research led, academic trials unit embedded within the Division of Clinical Studies at The Institute of Cancer Research, and has been established since the 1980s.

Dispensing medicines for a clinical trial (Jan Chlebik for the ICR, 2014)

The main objective of the ICR-CTSU is to lead the design, conduct and analysis of multi-centre national and international randomised controlled clinical trials of cancer treatments which will directly influence routine clinical practice within the NHS and worldwide.

The ICR-CTSU is one of only nine cancer clinical trials units to be accredited by the National Cancer Research Institute (NCRI) and is UK Clinical Research Collaboration (UK CRC) registered.

ICR-CTSU trials form an important component of the national portfolio of randomised trials in breast cancer, urological cancers, head and neck cancers, and radiotherapy techniques, and we have an expanding portfolio of exploratory phase II targeted treatment trials and trials in rarer tumour groups.

 


Division of Clinical Studies

The division carries out or coordinates high-quality trials and translational research at both an early phase – typically to test new targeted drugs – and a later stage.